Rubius Therapeutics, Inc.

MORGAN STANLEY

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/14/2023

Shares

62,273

Value ($000)

11

Weight

0.0%

2019 Q4 - 2022 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/14/2023	11	0.0%	62,273	12/31/2022
2022 Q3	11/14/2022	33	0.0%	76,330	9/30/2022
2022 Q2	10/27/2022	94	0.0%	111,100	6/30/2022
2022 Q1	10/27/2022	1,502	0.0%	272,737	3/31/2022
2021 Q4	2/14/2022	2,595	0.0%	268,082	12/31/2021
2021 Q3	11/15/2021	2,231	0.0%	124,723	9/30/2021
2021 Q2	8/23/2021	2,999	0.0%	122,862	6/30/2021
2021 Q1	5/17/2021	1,017	0.0%	38,356	3/31/2021
2020 Q4	2/16/2021	419	0.0%	55,299	12/31/2020
2020 Q3	11/13/2020	125	0.0%	24,928	9/30/2020
2020 Q2	8/14/2020	1,317	0.0%	220,195	6/30/2020
2020 Q1	5/26/2020	273	0.0%	61,574	3/31/2020
2019 Q4	2/14/2020	991	0.0%	104,261	12/31/2019